Comparative and Pragmatic Study of Simponi Aria Versus Remicade in Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Golimumab (Primary) ; Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms AWARE
- Sponsors Janssen
- 08 Nov 2017 Interim analysis (n=747) results assessing the golimumab and Infliximab utilization patterns, presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
- 17 Jun 2017 Interim anaysis results (n=353) presented at the 18th Annual Congress of the European League Against Rheumatism
- 08 Mar 2017 Planned End Date changed from 1 Feb 2021 to 25 Feb 2021.